These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

339 related items for PubMed ID: 22488474

  • 1. Hemopericardium in a patient treated with dabigatran etexilate.
    Barton CA, McMillian WD, Raza SS, Keller RE.
    Pharmacotherapy; 2012 May; 32(5):e103-7. PubMed ID: 22488474
    [Abstract] [Full Text] [Related]

  • 2. Rash associated with dabigatran etexilate.
    To K, Reynolds C, Spinler SA.
    Pharmacotherapy; 2013 Mar; 33(3):e23-7. PubMed ID: 23400964
    [Abstract] [Full Text] [Related]

  • 3. Dabigatran etexilate--a novel, reversible, oral direct thrombin inhibitor: interpretation of coagulation assays and reversal of anticoagulant activity.
    van Ryn J, Stangier J, Haertter S, Liesenfeld KH, Wienen W, Feuring M, Clemens A.
    Thromb Haemost; 2010 Jun; 103(6):1116-27. PubMed ID: 20352166
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Hospital-based clinical implications of the novel oral anticoagulant, dabigatran etexilate, in daily practice.
    Wilcox R, Pendleton RC, Smock KJ, Rodgers GM.
    Hosp Pract (1995); 2011 Aug; 39(3):23-34. PubMed ID: 21881389
    [Abstract] [Full Text] [Related]

  • 7. Hemopericardium and cardiac tamponade associated with dabigatran use.
    Dy EA, Shiltz DL.
    Ann Pharmacother; 2012 Aug; 46(7-8):e18. PubMed ID: 22786838
    [Abstract] [Full Text] [Related]

  • 8. Indirect comparisons of new oral anticoagulant drugs for efficacy and safety when used for stroke prevention in atrial fibrillation.
    Lip GY, Larsen TB, Skjøth F, Rasmussen LH.
    J Am Coll Cardiol; 2012 Aug 21; 60(8):738-46. PubMed ID: 22575324
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Plasma-diluted thrombin time to measure dabigatran concentrations during dabigatran etexilate therapy.
    Avecilla ST, Ferrell C, Chandler WL, Reyes M.
    Am J Clin Pathol; 2012 Apr 21; 137(4):572-4. PubMed ID: 22431533
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Dabigatran etexilate in clinical practice: confronting challenges to improve safety and effectiveness.
    Gulseth MP, Wittkowsky AK, Fanikos J, Spinler SA, Dager WE, Nutescu EA.
    Pharmacotherapy; 2011 Dec 21; 31(12):1232-49. PubMed ID: 22122184
    [Abstract] [Full Text] [Related]

  • 13. Treatments for stroke prevention in atrial fibrillation: a network meta-analysis and indirect comparisons versus dabigatran etexilate.
    Roskell NS, Lip GY, Noack H, Clemens A, Plumb JM.
    Thromb Haemost; 2010 Dec 21; 104(6):1106-15. PubMed ID: 20967400
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Rectal bleeding and hemostatic disorders induced by dabigatran etexilate in 2 elderly patients.
    Béné J, Saïd W, Rannou M, Deheul S, Coupe P, Gautier S.
    Ann Pharmacother; 2012 Jun 21; 46(6):e14. PubMed ID: 22669799
    [Abstract] [Full Text] [Related]

  • 18. Dabigatran etexilate: a novel oral thrombin inhibitor for thromboembolic disease.
    Bovio JA, Smith SM, Gums JG.
    Ann Pharmacother; 2011 May 21; 45(5):603-14. PubMed ID: 21540406
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Hemorrhagic gastritis with dabigatran in a patient with renal insufficiency.
    Fellows SE, Rosini JM, Curtis JA, Volz EG.
    J Emerg Med; 2013 Feb 21; 44(2):e221-5. PubMed ID: 22595629
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 17.